Skip to main content

Table 1 Basic characteristics of subjects, sperm parameters, and virological semen analyses

From: Mild COVID-19 has no detrimental effect on semen quality

 

COVID-19 (n = 25)

Control group (n = 12)

p-value

Age (years)

34.9 (26.7–43.1)

26.7 (24.0–34.8)

0.039a

Body mass index (kg/m2)

24.1 (23.1–26.9)

23.9 (22.3–26.1)

0.977a

Smokers

4 (16.0%)

5 (41.7%)

0.088c

Diabetes mellitus type 2

0

0

 

Hypertension in need of medical treatment

1

0

 

Paternity

6 (24.0%)

2 (16.7%)

0.612c

Result of fertility treatment

1 (4.0%)

1 (8.3%)

 > 0.999d

Testicular cancer

1 (4.0%)

1 (8.3%)

 > 0.999d

Semen volume (ml)

2.8 (2.0–3.9)

3.9 (2.2–5.0)

0.131b

Sperm concentration (106/ml)

44.0 (23.0–82.0)

93.5 (23.5–100.0)

0.140b

Total sperm number (106/ejaculate)

136.8 (54.0–228.1)

204.9 (83.1–550.0)

0.153b

Progressive motility (%)

25.0 (13.5–35.0)

20.0 (10.0–41.3)

0.708b

Total motility (%)

40.0 (18.5–40.0)

25.0 (15.0–47.5)

0.658b

Normozoospermia (n)

10 (40%)

5 (41.7%)

0.923c

Time of abstinence (days)

4 (3.0–6.5)

3.5 (2.3–4.0)

0.204b

SARS CoV-2-positive PCR of ejaculates (n)

0

0

 

SARS-CoV-2-positive cell cultures of ejaculates (n)

0

0

 
  1. Continuous data are presented as the median (Q1–Q3; Q1 = 25th percentile and Q3 = 75th percentile) and categorical data as frequencies (%)
  2. at-test
  3. bMann-Whitney U test
  4. cChi-squared test
  5. dFisher’s exact test